Afficher la notice abrégée

hal.structure.identifierPlateforme d'Aide à la Recherche Clinique [CHRU Nancy] [PARC]
hal.structure.identifierMaladies chroniques, santé perçue, et processus d'adaptation [APEMAC]
dc.contributor.authorTHILLY, Nathalie
hal.structure.identifierAssociation Lorraine pour le Traitement de l'Insuffisance Rénale [ALTIR]
dc.contributor.authorCHANLIAU, Jacques
hal.structure.identifierMaladies chroniques, santé perçue, et processus d'adaptation [APEMAC]
hal.structure.identifierService de Néphrologie [CHRU Nancy]
dc.contributor.authorFRIMAT, Luc
hal.structure.identifierService de Néphrologie-transplantation-dialyse [Bordeaux]
hal.structure.identifierBioingénierie tissulaire [BIOTIS]
dc.contributor.authorCOMBE, Christian
hal.structure.identifierService de Néphrologie-transplantation-dialyse [Bordeaux]
hal.structure.identifierComposantes innées de la réponse immunitaire et différenciation [CIRID]
dc.contributor.authorMERVILLE, Pierre
hal.structure.identifierService de Néphrologie-transplantation-dialyse [Bordeaux]
hal.structure.identifierFibrose hépatique et cancer du foie
dc.contributor.authorCHAUVEAU, Philippe
hal.structure.identifierService de Néphrologie [CH Boulogne-sur-Mer]
dc.contributor.authorBATAILLE, Pierre
hal.structure.identifierService de Néphrologie [CH Dunkerque]
dc.contributor.authorAZAR, Raymond
hal.structure.identifierSociété Pharmagest [Nancy]
dc.contributor.authorLAPLAUD, David
dc.contributor.authorNOËL, Christian
hal.structure.identifierService de Néphrologie [CHRU Nancy]
dc.contributor.authorKESSLER, Michèle
dc.date.accessioned2021-06-10T07:05:17Z
dc.date.available2021-06-10T07:05:17Z
dc.date.issued2017-04-05
dc.identifier.issn1471-2369
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/79015
dc.description.abstractEnBACKGROUND:Home telemonitoring has developed considerably over recent years in chronic diseases in order to improve communication between healthcare professionals and patients and to promote early detection of deteriorating health status. In the nephrology setting, home telemonitoring has been evaluated in home dialysis patients but data are scarce concerning chronic kidney disease (CKD) patients before and after renal replacement therapy. The eNephro study is designed to assess the cost effectiveness, clinical/biological impact, and patient perception of a home telemonitoring for CKD patients. Our purpose is to present the rationale, design and organisational aspects of this study.METHODS:eNephro is a pragmatic randomised controlled trial, comparing home telemonitoring versus usual care in three populations of CKD patients: stage 3B/4 (n = 320); stage 5D CKD on dialysis (n = 260); stage 5 T CKD treated with transplantation (n= 260). Five hospitals and three not-for-profit providers managing self-care dialysis situated in three administrative regions in France are participating. The trial began in December 2015, with a scheduled 12-month inclusion period and 12 months follow-up. Outcomes include clinical and biological data (e.g. blood pressure, haemoglobin) collected from patient records, perceived health status (e.g. health related quality of life) collected from self-administered questionnaires, and health expenditure data retrieved from the French health insurance database (SNIIRAM) using a probabilistic matching procedure.DISCUSSION:The hypothesis is that home telemonitoring enables better control of clinical and biological parameters as well as improved perceived health status. This better control should limit emergency consultations and hospitalisations leading to decreased healthcare expenditure, compensating for the financial investment due to the telemedicine system.TRIAL REGISTRATION:This study has been registered at ClinicalTrials.gov under NCT02082093 (date of registration: February 14, 2014).
dc.language.isoen
dc.publisherBioMed Central
dc.subject.enChronic kidney disease
dc.subject.enCost-effectiveness evaluation
dc.subject.enDialysis
dc.subject.enHome telemonitoring
dc.subject.enKidney transplantation
dc.subject.enTelemedicine
dc.title.enCost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design
dc.typeArticle de revue
dc.identifier.doi10.1186/s12882-017-0529-2
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologie/Urologie et Néphrologie
bordeaux.journalBMC Nephrology
bordeaux.page126
bordeaux.volume18
bordeaux.hal.laboratoriesBioingénierie Tissulaire (BioTis) - U1026*
bordeaux.issue1
bordeaux.institutionCNRS
bordeaux.institutionINSERM
bordeaux.institutionCHU de Bordeaux
bordeaux.institutionInstitut Bergonié
bordeaux.peerReviewedoui
hal.identifierinserm-02081206
hal.version1
hal.origin.linkhttps://hal.archives-ouvertes.fr//inserm-02081206v1
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMC%20Nephrology&rft.date=2017-04-05&rft.volume=18&rft.issue=1&rft.spage=126&rft.epage=126&rft.eissn=1471-2369&rft.issn=1471-2369&rft.au=THILLY,%20Nathalie&CHANLIAU,%20Jacques&FRIMAT,%20Luc&COMBE,%20Christian&MERVILLE,%20Pierre&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée